Javelin Pharmaceuticals
http://
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Javelin Pharmaceuticals
Distortion And Inflation In Measuring Pharma M&A
Five companies in big pharma’s top 20 have come through mergers in the past 10 years or so that changed them significantly. As measured by standard financial performance parameters, the processes at Takeda and Teva (and to some extent, at Allergan) seem relatively smooth and productive. Those at Pfizer and Merck don’t. But it depends on how you look at the numbers.
Execs On The Move, September 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
DigiSight Technologies Inc.
DigiSight Technologies Inc.'s cloud-based Paxos platform enables patients with acute ophthalmic conditions to self-administer 10 functional tests, ranging from visual acuity to color discrimination, using an application on a smartphone, tablet or other mobile device.
A Busy Year-End, In Brief: December Brings Slate Of Approvals, And Setbacks
In addition to a spate of FDA approvals closing out the year, Roche contended with trial failures and Actavis received a “complete response” letter for its nebivolol/valsartan combination.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Nasal
-
Drug Delivery
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice